ISCT Annual Meetings bring together over 3,000 participants from across the global cell and gene therapy (CGT) field, representing all key stakeholders involved in the development and delivery of CGT.
Attendees span the full CGT development pathway from early research through clinical development to commercialization and patient access including clinicians, researchers, and lab professionals; manufacturing, process development, and quality experts; regulatory authorities and policy leaders; industry representatives from biotech, pharma, and CDMOs. The Meeting also brings together hospital and treatment center teams, apheresis and cell collection specialists, supply chain and logistics experts, health economists and market access professionals, investors, and technology innovators including software, data, and AI experts. Early-stage professionals (ESPs) are also an important part of the ISCT community.
For more information regarding ISCT delegate demographics, see our webpage here